As cargo theft increases and qualified carrier capacity continues to decline,
pharmaceutical supply chains are facing a new reality. GDP-certified transportation is no
longer optional. It has become essential. 

Over the past year, regulatory enforcement has tightened across the industry. Stricter
CDL requirements and higher compliance standards have reduced the number of
eligible drivers and carriers. What was once a broader pool of transportation options is
now significantly more limited, especially for high-value and temperature-sensitive
shipments. 

At the same time, cargo theft has become more targeted and advanced.
 Recent data from the 2025 Verisk CargoNet Annual Analysis shows that total losses
reached nearly $725 million in 2025. This increase is not driven by a sharp rise in
incident volume, but by a shift toward high-value freight. Organized groups are focusing
on shipments that offer greater returns, which places pharmaceutical products at higher
risk during transit. 

These trends create a challenging environment. Shippers are managing reduced
capacity while facing greater exposure to theft and disruption. 
In this environment, not all carriers are equipped to handle the demands of
pharmaceutical logistics. GDP-certified transportation plays a critical role in ensuring
that products are handled under strict quality standards, including temperature control,
security protocols, and full traceability throughout the supply chain. This is where many
supply chains unknowingly introduce risk—by relying on capacity that cannot
meet evolving GDP and security standards. 

As the pool of qualified carriers continues to shrink, access to GDP-accredited capacity
is becoming increasingly limited. Companies that rely on general freight solutions face
greater risk, while those that prioritize GDP-certified networks are better positioned to
protect product integrity and patient safety. 
Recent developments in industry standards further reinforce this shift. GDP
accreditation, introduced in 2025, represents a significant step forward
in establishing consistent quality and handling standards across road freight, and
Tucker Company Worldwide was among the first five companies to achieve this
accreditation. 

If your pharmaceutical shipments require uncompromising compliance, security,
and control, now is the time to reassess your transportation strategy. 
Tucker Company Worldwide partners with shippers to identify risks, secure
qualified GDP capacity, and implement the standards that high-value freight
demands. 

Let’s evaluate your current network and ensure it’s built to protect what matters
most.